author-photo

Sarah Sheikh

Biogen Idec

59

Papers

1839

Citations

Citation Trend

Filter By

Papers (38) Sort By

Journal Conference Others

Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center

2021 Journal of gastrointestinal oncology
Show All
- Source
- Cite
- Save
Citations (1)
Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.

2020 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (7)
A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries

2019 BMC Neurology
Show All
- Source
- Cite
- Save
Citations (13)
Corrigendum to 'Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies. [Clinical Therapeutics 36 (2014) 1958-1971]

2018 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Predictors of an Opicinumab Treatment Effect and Identification of an Efficacy Subpopulation: A Post hoc Analysis of the SYNERGY Study (P3.408)

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Overall Response Score: A Novel Disability Endpoint That Allows for the Integrated Assessment of Improvement and Worsening over Time in Patients with MS (P4.380)

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Interim Results of an Open-Label Study to Assess the Effects of Delayed-release Dimethyl Fumarate on Lymphocyte Subsets and Immunoglobulins in Patients with Relapsing-remitting Multiple Sclerosis (P5.380)

2017 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

2015 Annals of clinical and translational neurology
Show All
- Source
- Cite
- Save
Citations (43)
Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE

2015
Show All
- Source
- Cite
- Save
Citations (0)
Five-Year Follow-up of Delayed-Release Dimethyl Fumarate in Relapsing-Remitting Multiple Sclerosis: MRI Outcomes from DEFINE, CONFIRM, and ENDORSE (P7.262)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (1)